AstraZeneca South Africa: Pumza Seokane

Pumza joined AstraZeneca in May 2016.

Pumza Seokane, HR director for South Africa and Sub-Saharan Africa at AstraZeneca, is a seasoned HR professional and leader with 17 years HR experience. Prior to her current role, she headed up the HR department at Aspen Pharmacare where, as the strategic partner to the South African commercial business, she oversaw the people strategy and drove all HR functions. She is passionate about leading teams, developing and empowering women, and strategically aligning HR to business. Pumza was awarded the HR Leadership Award in 2014 by Africa HR Leadership Awards and has previously been the second runner-up at the Judy Dlamini Awards for developing and empowering women. 


May 2016 – Present:   HR Director for SA&SSA, AstraZeneca

Jul 2011 – Apr 2016:   Head of HR, Aspen Pharmacare

Feb 2007 – Jul 2011:   HR Business Partner, Roche Diagnostics

Sep 2006 – Feb 2007: HR & Office Manager, MTV Networks Africa

Aug 2003 – Aug 2006: Group HR Manager, South African Broadcasting


Dec 1999 – Jul 2003:   HR Manager, Siemens


1997 – 1997:               Diploma in Organisation and Management, University

                                     of Cape Town 

1994 – 1996:                BA, University of Cape Town

About AstraZeneca

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines. The company’s three focus areas are Oncology, cardiovascular & metabolic disease (CVMD) and respiratory health issues, while it is also selectively active in the areas of autoimmunity, neuroscience and infection. AstraZeneca South Africa has proven its willingness to play a significant role in international R&D through a strong investment in clinical studies, across therapeutic areas, with added value for local doctors and patients.

The company is significantly involved in the rich pipeline of candidate drugs and has worked with specialists and primary care physicians throughout the country over the past years, resulting in a steady increase of trial work being awarded to the Clinical Research Department in South Africa, which attained key country status in 2000.